Table 2.
Variable | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
| ||||||
Risk ratio | 95% CI | P | Risk ratio | 95% CI | P | |
Gender | 1.042 | 0.874-1.611 | 0.674 | |||
Male vs Female | ||||||
Age (years) | 1.294 | 0.574-1.814 | 0.513 | |||
< 60 vs ≥ 60 | ||||||
Tumour number | 2.024 | 1.476-4.113 | 0.089 | |||
Solitary vs Multiple | ||||||
HBsAg | 1.486 | 0.971-2.481 | 0.407 | |||
Postive vs Negative | ||||||
AFP | 2.174 | 1.365-5.118 | 0.107 | |||
< 20 vs > 20 | ||||||
Tumor size | 2.342 | 1.784-3.921 | 0.006 | 1.787 | 1.169-3.274 | 0.035 |
< 5 cm vs ≥ 5 cm | ||||||
Lymphnode metastasis | 4.428 | 2.714-7.625 | 0.007 | 3.548 | 2.169-4.783 | 0.011 |
Absence vs Presence | ||||||
Clinical stage | 3.164 | 1.761-8.131 | 0.003 | 2.614 | 1.114-5.628 | 0.006 |
I-II vs III-IV | ||||||
GAS5 | 0.297 | 0.149-0.518 | < 0.001 | 0.417 | 0.244-0.617 | 0.002 |
low vs high |
Abbreviation: CI, confidence interval.